anmelden
FTSE All-Share
5.543,09
PKT
+1,85
PKT
+0,03
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.07.18 | AstraZeneca overweight | Barclays Capital | |
| 27.07.18 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 27.07.18 | Shell (ex Royal Dutch Shell) buy | S&P Capital IQ | |
| 27.07.18 | BAT buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.07.18 | BAT buy | Deutsche Bank AG | |
| 27.07.18 | Shell (ex Royal Dutch Shell) Hold | Société Générale Group S.A. (SG) | |
| 27.07.18 | Shell (ex Royal Dutch Shell) overweight | Barclays Capital | |
| 27.07.18 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 27.07.18 | Diageo buy | Goldman Sachs Group Inc. | |
| 27.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 27.07.18 | BAT buy | Goldman Sachs Group Inc. | |
| 26.07.18 | Vodafone Group Outperform | RBC Capital Markets | |
| 26.07.18 | Diageo Sector Perform | RBC Capital Markets | |
| 26.07.18 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 26.07.18 | BAT buy | Goldman Sachs Group Inc. | |
| 26.07.18 | GSK buy | UBS AG | |
| 26.07.18 | GSK Hold | S&P Capital IQ | |
| 26.07.18 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 26.07.18 | Vodafone Group overweight | Barclays Capital | |
| 26.07.18 | AstraZeneca Neutral | UBS AG | |
| 26.07.18 | Vodafone Group buy | Deutsche Bank AG | |
| 26.07.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.07.18 | Diageo buy | UBS AG | |
| 26.07.18 | GSK Hold | Deutsche Bank AG | |
| 26.07.18 | Diageo buy | Goldman Sachs Group Inc. | |
| 26.07.18 | Prudential buy | UBS AG | |
| 26.07.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 26.07.18 | BAT overweight | JP Morgan Chase & Co. | |
| 26.07.18 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 26.07.18 | Unilever Neutral | Credit Suisse Group | |
| 26.07.18 | Vodafone Group Outperform | Credit Suisse Group | |
| 26.07.18 | GSK Neutral | Credit Suisse Group | |
| 25.07.18 | GSK buy | Goldman Sachs Group Inc. | |
| 25.07.18 | Vodafone Group buy | UBS AG | |
| 25.07.18 | Glencore Outperform | RBC Capital Markets | |
| 25.07.18 | GSK buy | UBS AG | |
| 25.07.18 | GSK buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.07.18 | London Stock Exchange (LSE) Outperform | Credit Suisse Group | |
| 25.07.18 | Vodafone Group overweight | Barclays Capital | |
| 25.07.18 | Rio Tinto Underperform | RBC Capital Markets |